Cutler Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Cutler Group’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-625	Closed	-$28K	–	6482
2017 Q3	$28K	Buy	625 +12	+2%	+$455	﹤0.01%	2821
2017 Q2	$12K	Sell	613 -412	-40%	-$19.8K	﹤0.01%	4020
2017 Q1	$11K	Buy	1,025 +512	+100%	+$20K	﹤0.01%	3983
2016 Q4	$6K	Buy	+513	New	+$16.9K	﹤0.01%	4833

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Cutler Group's GNCA Position: Q2 2022 in Review

Cutler Group sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 900 shares — an estimated $1K sold.

Cutler Group first reported a position in GNCA in Q2 2017 and held it in 11 quarters. The position peaked at $25K in Q2 2017. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Cutler Group reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Cutler Group sold 900 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $1K.
Cutler Group first reported a position in Genocea Biosciences, Inc. in Q2 2017 and held it in 11 quarters.
Cutler Group's Genocea Biosciences, Inc. position peaked at $25K in Q2 2017.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.